[Effects evaluation of middle mode artificial liver in treatment of severe hepatitis].
OBJECTIVE
To evaluate the clinical efficacy and safety of middle mode artificial liver-plasma pheresis in treatment of severe hepatitis.


METHODS
Seventeen patients with severe hepatitis were treated with plasma pheresis. The results of liver function, renal function, blood routine, prothrombin time (PT), prothrombin time activity (PTa) before and after the treatment were analyzed. All patients were observed closely.


RESULTS
Symptoms of patients treated with plasma pheresis were improved, and the total effective rate reached 58.8 percent, but the survival rate was only 11.8 percent. Compared with those before the therapy, there were significant differences in aminotransferase, total bilirubin, direct bilirubin, PT, PTa and total protein level after treatment (P<0.05 or P<0.01). The side-effects were mild.


CONCLUSIONS
Middle artificial liver is effective in the treatment of severe hepatitis.
He
Nian-hai
NH
Research Institute of Infectious Disease, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.
Wang
Ying-jie
YJ
Liu
Jun
J
Li
Jia-jia
JJ
Liu
Guo-dong
GD
Wang
Yu-ming
YM
D000328:Adult; D005260:Female; D006505:Hepatitis / Q000628:therapy*; D006801:Humans; D008099:Liver / Q000503:physiopathology*; D008111:Liver Function Tests; D019164:Liver, Artificial; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome